Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Pediatrics in Review. 1987;9:191-196.)
© 1987 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McIntosh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McIntosh, K.

Respiratory Syncytial Virus Infections in Infants and Children: Diagnosis and Treatment

Kenneth McIntosh MD1
 1 Graduate of Harvard College and Harvard Medical School and completed a residency in Internal Medicine at the Peter Brent Brigham Hospital Boston

Respiratory syncytial virus is the most important cause of acute viral pneumonia and bronchiolitis in infants and children. Recent advances in diagnostic methods have put precise and rapid identification of cases within the capability of many hospital laboratories. Aerosolized ribavirin is now available for treatment of respiratory syncytial virus infections, and it should be used in selected instances, principally with the intent of preventing the necessity for intubation and ventilation. The criteria we use for selection of those patients include infants with underlying cardiopulmonary disease who are at high risk for severe disease, although normal infants occasionally deteriorate and should be considered candidates. With judicious use of laboratory techniques to make an accurate diagnosis and ribavirin treatment, the overall morbidity of respiratory syncytial virus infections should be significantly lessened.




This article has been cited by other articles:


Home page
 ChestHome page
D. Prais, D. Danino, T. Schonfeld, J. Amir, and for the Israeli RSV Monitoring Group
Impact of Palivizumab on Admission to the ICU for Respiratory Syncytial Virus Bronchiolitis: A National Survey{dagger}
Chest, October 1, 2005; 128(4): 2765 - 2771.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. P. Stevens, R. A. Sinkin, C. B. Hall, W. M. Maniscalco, and K. M. McConnochie
Respiratory Syncytial Virus and Premature Infants Born at 32 Weeks' Gestation or Earlier: Hospitalization and Economic Implications of Prophylaxis
Arch Pediatr Adolesc Med, January 1, 2000; 154(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D. Isaacs
Bronchiolitis
BMJ, January 7, 1995; 310(6971): 4 - 5.
[Full Text]


HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 1987 by the American Academy of Pediatrics.